Three insights:
1. The new facility will add to its current 20,000-square-foot space.
2. MiRus is collaborating with hospital systems and surgeons to develop new products in implants, robotics, navigation and analytics.
3. In March, MiRus received FDA 510(k) approval for MoRe — a molybdenum rhenium superalloy for medical implants.
“With a view to developing market leading products to meet clinical needs in deformity, lateral and upper extremity, we are looking to add the best implant design engineers and manufacturing engineers,” said Jay Yadav, MD, founder and CEO of MiRus.
More articles on devices:
Zimmer Biomet replaces retiring CFO
Stryker expands overseas & more: 6 device company key notes
Pacira appoints former Johnson & Johnson exec Max Reinhardt president
